QVT Financial LP - Q3 2016 holdings

$2.65 Billion is the total value of QVT Financial LP's 71 reported holdings in Q3 2016. The portfolio turnover from Q2 2016 to Q3 2016 was 34.7% .

 Value Shares↓ Weighting
AXGT NewAXOVANT SCIENCES LTD$1,050,000,00075,000,000
+100.0%
39.58%
XBI BuySPDR SERIES TRUSTput$316,986,000
+37.8%
4,781,800
+12.4%
11.95%
-24.5%
 MICROCHIP TECHNOLOGY INCsdcv 2.125%12/1$82,376,000
+23.1%
31,764,0000.0%3.10%
-32.6%
SellVERISIGN INCsdcv 3.250% 8/1$79,419,000
-21.9%
34,600,000
-13.5%
2.99%
-57.2%
BuyTAL ED GROUPnote 2.500% 5/1$78,913,000
+37.3%
29,000,000
+20.8%
2.98%
-24.8%
GS SellGOLDMAN SACHS GROUP INC$68,952,000
-11.7%
427,558
-18.7%
2.60%
-51.7%
NewNOVELLUS SYS INCnote 2.625% 5/1$56,518,00020,193,000
+100.0%
2.13%
ABUS NewARBUTUS BIOPHARMA CORP$55,087,00016,013,540
+100.0%
2.08%
BuySHIP FINANCE INTERNATIONAL Lnote 3.250% 2/0$43,674,000
+8.4%
40,500,000
+6.6%
1.65%
-40.7%
MMYT SellMAKEMYTRIP LIMITED MAURITIUS$39,612,000
+36.6%
1,794,024
-11.8%
1.49%
-25.2%
INTC  INTEL CORP$35,108,000
+15.1%
930,0040.0%1.32%
-37.0%
SellCLOVIS ONCOLOGY INCnote 2.500% 9/1$34,670,000
+11.8%
36,295,000
-16.2%
1.31%
-38.8%
BuyWELLPOINT INCnote 2.750%10/1$32,718,000
+7.9%
18,500,000
+12.1%
1.23%
-40.9%
 CTRIP COM INTL LTDnote 1.250%10/1$32,437,000
+5.9%
25,000,0000.0%1.22%
-42.0%
SRPT BuySAREPTA THERAPEUTICS INC$30,486,000
+288.9%
496,434
+20.8%
1.15%
+112.8%
IBB BuyISHARES TRnasdq biotec etf$27,131,000
+75.2%
93,730
+55.8%
1.02%
-4.0%
NRE SellNORTHSTAR REALTY EUROPE CORP$25,339,000
+15.7%
2,314,090
-2.3%
0.96%
-36.7%
NYT SellNEW YORK TIMES COcl a$23,295,000
-17.3%
1,949,409
-16.3%
0.88%
-54.7%
AGEN SellAGENUS INC$23,110,000
+55.1%
3,218,707
-12.5%
0.87%
-15.0%
XLRN SellACCELERON PHARMA INC$23,044,000
-3.5%
636,764
-9.3%
0.87%
-47.1%
SellINTEL CORPsdcv 12/1$21,557,000
-16.6%
15,500,000
-22.5%
0.81%
-54.3%
COG NewCABOT OIL & GAS CORP$21,278,000824,742
+100.0%
0.80%
EQC SellEQUITY COMWLTH$20,550,000
-11.8%
680,000
-15.0%
0.78%
-51.7%
AMBA NewAMBARELLA INC$20,307,000275,877
+100.0%
0.77%
KANG BuyIKANG HEALTHCARE GROUP INCsponsored adr$20,225,000
+23.6%
1,118,340
+25.4%
0.76%
-32.3%
ARWR BuyARROWHEAD PHARMACEUTICALS IN$18,788,000
+72.5%
2,556,256
+24.8%
0.71%
-5.6%
ATEX  PDVWIRELESS INC$18,466,000
+4.3%
902,5990.0%0.70%
-42.9%
NAT SellNORDIC AMERICAN TANKERS LIMIput$17,768,000
-29.4%
1,757,500
-3.0%
0.67%
-61.3%
THC SellTENET HEALTHCARE CORP$15,335,000
-30.2%
676,765
-14.8%
0.58%
-61.7%
 DHT HOLDINGS INCdebt 4.500%10/0$15,172,000
-5.2%
17,000,0000.0%0.57%
-48.0%
MRVL SellMARVELL TECHNOLOGY GROUP LTDord$15,118,000
+12.4%
1,139,262
-19.3%
0.57%
-38.4%
ICPT BuyINTERCEPT PHARMACEUTICALS IN$15,123,000
+44.7%
91,881
+25.4%
0.57%
-20.7%
LBIO BuyLION BIOTECHNOLOGIES INC$14,335,000
+10.7%
1,751,509
+9.6%
0.54%
-39.4%
 CTRIP COM INTL LTDnote 1.000% 7/0$14,166,000
+3.2%
13,000,0000.0%0.53%
-43.5%
PYPL NewPAYPAL HLDGS INC$14,101,000344,190
+100.0%
0.53%
XLNX  XILINX INC$12,871,000
+17.8%
236,8550.0%0.48%
-35.5%
BMRN BuyBIOMARIN PHARMACEUTICAL INC$12,391,000
+63.8%
133,933
+37.7%
0.47%
-10.4%
TSM  TAIWAN SEMICONDUCTOR MFG LTDput$12,236,000
+16.6%
400,0000.0%0.46%
-36.1%
SellWEBMD HEALTH CORPnote 2.500% 1/3$11,490,000
-17.3%
11,000,000
-12.0%
0.43%
-54.7%
WFC SellWELLS FARGO & CO NEW$11,291,000
-27.7%
255,000
-22.7%
0.43%
-60.4%
BRFS  BRF SAsponsored adr$10,357,000
+22.5%
607,1120.0%0.39%
-33.0%
YY NewYY INC$10,160,000190,700
+100.0%
0.38%
AR NewANTERO RES CORP$10,063,000373,413
+100.0%
0.38%
AVXS SellAVEXIS INC$9,262,000
+3.4%
224,756
-7.4%
0.35%
-43.4%
TNK  TEEKAY TANKERS LTDcl a$9,247,000
-15.1%
3,654,7760.0%0.35%
-53.5%
XNCR SellXENCOR INC$8,740,000
+18.9%
356,873
-7.8%
0.33%
-35.0%
FIT  FITBIT INCcl a$8,600,000
+21.4%
579,5020.0%0.32%
-33.5%
EPZM SellEPIZYME INC$8,368,000
-15.9%
850,446
-12.5%
0.32%
-54.0%
SCTY  SOLARCITY CORP$7,957,000
-18.3%
406,8160.0%0.30%
-55.2%
SCTY  SOLARCITY CORPput$7,941,000
-18.3%
406,0000.0%0.30%
-55.3%
BLCM SellBELLICUM PHARMACEUTICALS INC$7,738,000
+17.5%
388,839
-23.4%
0.29%
-35.5%
JPM SellJPMORGAN CHASE & CO$7,325,000
-34.5%
110,000
-38.9%
0.28%
-64.2%
ZXAIY  CHINA ZENIX AUTO INTL LTDads$5,813,000
+50.5%
6,074,8050.0%0.22%
-17.7%
NewINTERCEPT PHARMACEUTICALS INnote 3.250% 7/0$5,638,0005,000,000
+100.0%
0.21%
BGNE  BEIGENE LTDsponsored adr$5,238,000
+3.4%
170,0000.0%0.20%
-43.6%
RGNX SellREGENXBIO INC$5,197,000
+53.1%
370,943
-12.6%
0.20%
-16.2%
ADAP SellADAPTIMMUNE THERAPEUTICS PLCsponds adr$5,092,000
-20.3%
722,233
-7.8%
0.19%
-56.4%
ASMB  ASSEMBLY BIOSCIENCES INC$5,059,000
+35.3%
807,6010.0%0.19%
-25.7%
 YY INCnote 2.250% 4/0$4,950,000
+0.4%
5,000,0000.0%0.19%
-44.8%
IMAX NewIMAX CORP$4,908,000169,400
+100.0%
0.18%
NAT SellNORDIC AMERICAN TANKERS LIMI$4,864,000
-69.0%
481,120
-57.5%
0.18%
-83.1%
BLUE  BLUEBIRD BIO INC$3,999,000
+56.6%
59,0020.0%0.15%
-14.2%
FRO  FRONTLINE LTD$2,930,000
-8.5%
408,3410.0%0.11%
-50.0%
OCRX  OCERA THERAPEUTICS INC$2,335,000
+56.9%
932,0860.0%0.09%
-13.7%
TCON SellTRACON PHARMACEUTICALS INC$2,014,000
+42.7%
334,206
-8.0%
0.08%
-21.6%
ATHM NewAUTOHOME INCsp adr rp cl a$1,974,00081,400
+100.0%
0.07%
AKTX  AKARI THERAPEUTICS PLCsponsored adr$1,833,000
-36.9%
263,9210.0%0.07%
-65.5%
PTN  PALATIN TECHNOLOGIES INC$1,779,000
+42.5%
4,039,3740.0%0.07%
-22.1%
SRLP  SPRAGUE RES LP$844,000
-12.4%
39,9790.0%0.03%
-51.5%
MDGN SellMEDGENICS INC$688,000
-84.9%
123,500
-85.5%
0.03%
-91.7%
FCSC SellFIBROCELL SCIENCE INC$335,000
-84.8%
465,672
-75.7%
0.01%
-91.4%
DNAI ExitPRONAI THERAPEUTICS INC$0-70,000
-100.0%
-0.01%
FPRX ExitFIVE PRIME THERAPEUTICS INC$0-48,582
-100.0%
-0.14%
ADRO ExitADURO BIOTECH INC$0-191,954
-100.0%
-0.15%
MRTX ExitMIRATI THERAPEUTICS INC$0-509,750
-100.0%
-0.19%
ExitARRAY BIOPHARMA INCnote 3.000% 6/0$0-4,600,000
-100.0%
-0.27%
HALO ExitHALOZYME THERAPEUTICS INC$0-500,449
-100.0%
-0.30%
MFRM ExitMATTRESS FIRM HLDG CORP$0-130,738
-100.0%
-0.30%
GLNG ExitGOLAR LNG LTD BERMUDA$0-300,283
-100.0%
-0.32%
RLGY ExitREALOGY HLDGS CORP$0-365,645
-100.0%
-0.73%
CYTR ExitCYTRX CORP$0-5,423,037
-100.0%
-0.83%
ZG ExitZILLOW GROUP INCcl a$0-600,000
-100.0%
-1.51%
MU ExitMICRON TECHNOLOGY INCcall$0-1,700,000
-100.0%
-1.61%
Z ExitZILLOW GROUP INCcl c cap stk$0-665,000
-100.0%
-1.66%
ExitWESCO INTL INCdbcv 6.000% 9/1$0-13,550,000
-100.0%
-1.69%
QIHU ExitQIHOO 360 TECHNOLOGY CO LTDads$0-734,731
-100.0%
-3.69%
Original filings

The following EDGAR filing(s) were analyzed to create this report:

  • View 13F-HR filed 2016-11-14
Signatures

The EDGAR filing(s) were signed by:

Top long-term holdings
NameQuarters ownedLatest quarter ownedMax weighting
MAKEMYTRIP LIMITED MAURITIUS38Q3 20236.2%
NEW YORK TIMES CO34Q3 20232.6%
ACCELERON PHARMA INC32Q3 20212.8%
JPMORGAN CHASE & CO32Q3 20212.2%
SAREPTA THERAPEUTICS INC32Q3 20231.1%
BIOMARIN PHARMACEUTICAL INC32Q3 20230.5%
GOLDMAN SACHS GROUP INC30Q3 20235.4%
ACADIA PHARMACEUTICALS INC28Q3 20230.2%
WELLS FARGO CO NEW27Q4 20201.5%
NEXSTAR MEDIA GROUP INC26Q3 20233.4%

View QVT Financial LP's complete holdings history.

Latest significant ownerships (13-D/G)
QVT Financial LP Q3 2016 significant holdings filed using form 13D/G when ownership exceeds 5% of a company's total stock issue.
FiledShares Percentage
MP Materials Corp. / DEMay 18, 20238,853,7125.0%
Grindrod Shipping Holdings Ltd.Sold outFebruary 14, 202200.0%
AEHR TEST SYSTEMSSold outFebruary 14, 202000.0%
Arbutus Biopharma CorpSold outJuly 12, 201900.0%
Axovant Gene Therapies Ltd.Sold outJuly 12, 201900.0%
Myovant Sciences Ltd.Sold outJuly 12, 201900.0%
Urovant Sciences Ltd.Sold outJuly 12, 201900.0%
Axovant Sciences Ltd.March 19, 2019105,952,38158.2%
Hunter Maritime Acquisition Corp.Sold outFebruary 14, 201900.0%
AGENUS INCFebruary 14, 20183,201,2633.2%

View QVT Financial LP's complete significant-ownership history.

Latest filings
TypeFiled
42024-03-07
SC 13G/A2024-03-07
13F-HR2024-02-14
SC 13G/A2024-02-14
13F-HR2023-11-14
42023-10-02
1442023-09-28
13F-HR2023-08-14
SC 13D/A2023-05-18
13F-HR2023-05-15

View QVT Financial LP's complete filings history.

Compare quarters

Export QVT Financial LP's holdings